DPY30 and colorectal carcinoma: Upon clinicopathological characteristics correlation analysis, elevated DPY30 protein levels positively correlated with pathological grading (P = 0.0348), tumor size (P = 0.0192), TNM stage (P = 0.0365), and tumor location (P = 0.019) in CRC patients (Table 3).